SCHEMBL409670

SCHEMBL409670

Cc1c(-c2ccccc2)ccc(C(=O)O)c1C(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
HNF4A P41235 2/20 0.41
PTGS1 P23219 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
PTGS2 P35354 2/20 0.41
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 2/20 0.41
AKR1C1 Q04828 2/20 0.41
MAPT P10636 2/20 0.41
FABP2 P12104 1/20 0.41
TSHR P16473 1/20 0.41
AKR1C4 P17516 1/20 0.41
ADRA2B P18089 1/20 0.41
CHRM3 P20309 1/20 0.41
HTR2C P28335 1/20 0.41
DRD3 P35462 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28360369 0.80 PTGS1 (0.38) ALDH1A1HNF4APTGS1MEN1KMT2A
SCHEMBL6974190 0.79 ALDH1A1 (0.49) ALDH1A1HNF4AMEN1KMT2AAKR1C3
SCHEMBL8529625 0.79 PTGS2 (0.38) ALDH1A1HNF4APTGS1MEN1KMT2A
SCHEMBL28755647 0.78 DHODH (0.47) ALDH1A1HNF4APTGS1MEN1KMT2A
SCHEMBL4849742 0.76 ALDH1A1 (0.51) ALDH1A1HNF4AMEN1KMT2AAKR1C3
SCHEMBL14690430 0.76 HNF4A (0.59) ALDH1A1HNF4AMEN1KMT2AAKR1C3
SCHEMBL17309702 0.76 HNF4A (0.50) ALDH1A1HNF4AMEN1KMT2AAKR1C3
SCHEMBL8530215 0.76 MEN1 (0.39) ALDH1A1HNF4APTGS1MEN1KMT2A
SCHEMBL17309706 0.73 HNF4A (0.50) ALDH1A1HNF4AMEN1KMT2AAKR1C3
SCHEMBL27489890 0.73 ALDH1A1 (0.46) ALDH1A1HNF4AMEN1KMT2AAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815919-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-26 US disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022109-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB ALDH1A1 510/4885HNF4A 2407/4885PTGS1 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.